Bellwood and Sunnybrook are working together to bring innovative neuromodulation services to clients who have treatment-resistant psychiatric disorders or severe addiction. The Harquail Centre for Neuromodulation at Sunnybrook is the world’s first to offer a complete range of neuromodulation strategies in one state-of-the-art facility. Our internationally recognized researchers and scientists are investigating minimal- and non-invasive technology to target pathways in the brain that are at the root of the most common and challenging brain disorders including: Alzheimer’s disease, Parkinson’s Disease, ALS, essential tremor, major depression, OCD, and others. The experts at The Harquail Centre are committed to investigating and developing novel treatments that are individualized and tailored to our patients’ needs.
Clients who attend Bellwood for treatment, may be eligible for a referral to the The Harquail Centre for Neuromodulation at Sunnybrook. During the referral process the clinical team at Sunnybrook will evaluate your ability to participate. If you have specific questions about this treatment modality please speak to Sunnybrook directly.
What is Neuromodulation?
At the Harquail Centre for Neuromodulation, the focus of this rapidly evolving field is on the ability to influence brain circuitry to stop, start and interrupt the systems at the root of the most common and challenging brain disorders. This can be accomplished using a variety of neuromodulation treatments which are led by the expertise of our world-leading researchers and clinical teams who strive beyond excellence in providing treatment options and care to patients.
For more information, please visit our website at https://sunnybrook.ca/research/content/?page=sri-centre-harquail. If you have any questions, please contact us at [email protected] (please indicate in the subject line your diagnosis and which study you are inquiring about) or leave a voice mail at 416-480-6100 x3773 indicating the trial you are inquiring about.